Best strategy for post op pain with novalgin, paracetamol, ibuprofen, piritramid. What are the contraindications for each and when can the 2nd Dosis be given. Maximal daily dose
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching the Web
postoperative pain management novalgin paracetamol ibuprofen piritramide dosing contraindications
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading Web Page
https://www.compva.com/science/drug-therapy-in-pain-manageme…
I now have sufficient data to compile a comprehensive answer. Let me put this all together.
Post-Op Pain Management: Novalgin, Paracetamol, Ibuprofen & Piritramide
Overall Strategy: Descending Multimodal Analgesia
For postoperative pain, the WHO step ladder is applied in reverse - start strong, then step down as pain decreases. Non-opioid analgesics (Level 1) should always be combined with Level 2/3 agents. The goal is opioid-sparing - using piritramide only for moderate-severe pain while anchoring the regimen with the three non-opioids.
Typical descending approach:
- Day 0-1 (severe pain): Piritramide (IV/PCA) + Novalgin/Metamizole IV + Paracetamol IV/oral
- Day 1-3 (moderate pain): Novalgin + Paracetamol ± Ibuprofen (if tolerated), reduce/stop piritramide
- Day 3+ (mild pain): Ibuprofen + Paracetamol, as needed
Drug-by-Drug Reference
1. Novalgin (Metamizole / Dipyrone)
| Mechanism | Inhibits prostaglandin synthesis centrally + peripherally; particularly effective for visceral/colic pain; mild spasmolytic |
| Dose (adult) | 500 mg - 1000 mg per dose (commonly 1 g IV over 15 min) |
| Interval (next dose) | Every 6-8 hours (can be given every 6 h IV if needed) |
| Max daily dose | 4 g/day (4 × 1 g); some protocols allow up to 5 g/day under close monitoring |
| Onset | IV: 15-30 min; oral: 30-45 min |
| Duration | 4-8 hours |
Contraindications:
- Hematological diseases (bone marrow suppression, agranulocytosis risk - key concern)
- Bronchial asthma (especially analgesic-induced asthma / Samter's triad)
- Hypersensitivity to pyrazolones
- G6PD deficiency (hemolysis risk)
- Hepatic porphyria
- Pregnancy (especially 1st trimester and at term - risk of premature closure of ductus arteriosus)
- Children < 3 months / < 5 kg
- Severe hepatic or renal impairment
- Note: Banned in several countries (Scandinavia, Japan, USA) due to risk of agranulocytosis (~1:1,000,000). Patients should be informed of this risk. Particularly useful when NSAIDs are contraindicated (renal insufficiency, GI ulcers).
2. Paracetamol (Acetaminophen)
| Mechanism | Central COX inhibition + endocannabinoid system modulation; analgesic and antipyretic but NOT anti-inflammatory |
| Dose (adult) | 500 mg - 1000 mg per dose |
| Interval (next dose) | Every 4-6 hours (minimum 4 h between doses) |
| Max daily dose | 4 g/day in healthy adults; 2-3 g/day in hepatic impairment, chronic alcohol use, or low body weight (<50 kg) |
| Onset | IV: 5-10 min; oral: 30-60 min |
| Duration | 4-6 hours |
Contraindications:
- Severe hepatic impairment / acute hepatitis / decompensated cirrhosis (use with extreme caution)
- Hypersensitivity to paracetamol
- Caution: Chronic alcohol use (>3 drinks/day), malnutrition/anorexia (depleted glutathione stores), G6PD deficiency (relative)
- Not contraindicated in renal impairment or GI ulcer history - this makes it a valuable drug when NSAIDs are contraindicated
- Note: Paracetamol is safe in compensated cirrhosis at adjusted doses (2-2.6 g/day). Do NOT combine with other paracetamol-containing preparations (cold/flu remedies).
3. Ibuprofen
| Mechanism | Non-selective COX-1/COX-2 inhibitor - anti-inflammatory, analgesic, antipyretic |
| Dose (adult) | 400-800 mg per dose |
| Interval (next dose) | Every 6-8 hours (400 mg can be given every 4-6 h, 800 mg every 8 h) |
| Max daily dose | 2400 mg/day (prescription dose); 1200 mg/day for OTC use |
| Onset | Oral: 30-60 min; IV: 10-15 min |
| Duration | 4-8 hours |
Contraindications:
- Renal impairment (eGFR < 50 mL/min is a hard contraindication; causes renal hypoperfusion and can precipitate acute kidney injury - especially relevant post-op)
- Active GI ulcer / GI bleeding (COX-1 inhibition impairs mucosal protection)
- Severe heart failure (NYHA III-IV)
- Severe coronary artery disease / recent MI / history of atherothrombosis (PAD, stroke)
- Analgesic-induced asthma (NSAID-sensitive asthma) - cross-reacts with other NSAIDs
- Concurrent therapeutic anticoagulation (increased bleeding risk; weak relative contraindication)
- Coagulopathy / platelet dysfunction (reversible platelet inhibition - concern for surgical bleeding)
- Pregnancy (especially ≥ 20 weeks - premature ductus closure, oligohydramnios; avoid in 3rd trimester entirely)
- Post-op caution: Avoid in hypovolemia, post-major surgery with high bleeding risk, bone surgery where NSAIDs may impair fracture healing (controversial but considered)
- If patient is on low-dose ASA for cardiovascular protection: allow a 2-hour interval between ibuprofen and ASA (ibuprofen can block ASA's antiplatelet effect)
4. Piritramide
| Mechanism | Synthetic opioid (piperidine derivative), primarily mu-opioid receptor agonist |
| Potency | ~0.7 relative to morphine (i.e., 15 mg piritramide ≈ 10 mg morphine) |
| Dose (adult) | IM/IV bolus: 7.5-15 mg; PCA: typically 1.5-2 mg bolus, 10-15 min lockout; titration: 3.75-4.5 mg IV increments |
| Interval (next dose) | Bolus: Every 4-6 hours (IM/IV); PCA lockout 10-15 min |
| Max daily dose | No fixed absolute maximum - titrate to effect; typical range 30-60 mg/day in PCA; individual doses not to exceed 15 mg IV |
| Onset | IV: 1-5 min; IM: 15-30 min |
| Duration | 4-6 hours per dose; slow elimination - accumulation risk with renal impairment |
Contraindications:
- Respiratory depression / severe COPD / respiratory failure (all opioids)
- Concurrent MAO inhibitor use (risk of serotonergic crisis)
- Ileus / raised intracranial pressure (relative)
- Severe hepatic impairment (reduced metabolism)
- Severe renal impairment (slower elimination - dose reduction required)
- Hypersensitivity to piritramide
- Alcohol/sedative intoxication
- Not recommended as first-line for mild pain (reserve for moderate-severe postoperative pain)
- Common side effects: Nausea/vomiting, sedation, respiratory depression, pruritus, urinary retention, ileus - same profile as morphine but reportedly slightly less hemodynamic instability
Combination Timing Strategy (Practical Example)
Staggered approach for continuous pain coverage (Day 1 post-op):
| Time | Drug |
|---|---|
| 06:00 | Paracetamol 1 g IV/oral |
| 08:00 | Novalgin 1 g IV |
| 12:00 | Paracetamol 1 g + Ibuprofen 400 mg |
| 14:00 | Novalgin 1 g IV |
| 18:00 | Paracetamol 1 g |
| 20:00 | Novalgin 1 g + Ibuprofen 400 mg |
| 00:00 | Paracetamol 1 g |
| PRN | Piritramide 7.5 mg IV for NRS ≥ 5, max every 4-6 h |
This stays within: Paracetamol 4 g, Novalgin 4 g, Ibuprofen 800 mg (conservative), and uses piritramide only as rescue.
Quick Comparison Summary
| Drug | Max Daily Dose | Dosing Interval | Key Contraindication |
|---|---|---|---|
| Novalgin | 4 g | Every 6-8 h | Hematological disease, asthma |
| Paracetamol | 4 g (2.6 g if liver disease) | Every 4-6 h | Hepatic failure |
| Ibuprofen | 2400 mg | Every 6-8 h | Renal impairment, GI ulcer, heart failure |
| Piritramide | ~60 mg (titrate) | Every 4-6 h (bolus) | Respiratory depression, MAOI use |
Key principle: Novalgin is particularly valuable when NSAIDs (ibuprofen) are contraindicated due to renal or GI issues. Paracetamol is safe in renal impairment. Piritramide should be combined with - not replace - the non-opioids to minimize opioid dose and side effects.
Sources: Miller's Anesthesia 10e (Piritramide section, p.2865); Barash Clinical Anesthesia 9e; Schwartz's Principles of Surgery 11e; compva.com drug therapy in pain management; postoperative analgesia routes review - PMC
This is a shared conversation. Sign in to Orris to start your own chat.